Business
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aeroso...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n\n \n \n \n MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols.\n \n \n Products include metered dose inhalers and aerosol sublingual sprays.\n \n \n MediPharm will assume existing Remidose sales allowing for immediate revenue opportunity.\n \n \n Transaction is non-dilutive, with 100% performance-based payment through a royalty model.\n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n June 20, 2024\n \n \n /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (\"MediPharm\", \"MediPharm Labs\" or the \"Company\") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has entered into a licencing agreement with Remidose Aerosols Inc. (\"Remidose\") to acquire the exclusive rights for advanced cannabis products (the \"Agreement\").\n \n \n \n \n \n \n \n \n \n The Agreement allows for an immediate revenue opportunity as current Remidose customers will be serviced through MediPharm starting\n \n August 2024\n \n . These existing customers include Canadian direct-to-patient medical platforms and international medical distributors.  MediPharm plans to use its existing GMP infrastructure, customer channels and wellness sales expertise to expand the customer base of these advanced products in\n \n Canada\n \n and globally.\n \n \n These advanced innovative products fall into two main categories:\n \n \n \n 1. Metered Dose Inhalers:\n \n This metered dose inhaler is the same device used in the pharmaceutical industry. The inhalation format provides rapid onset without the adverse effects of smoking and combustible vape cartridges now being used by cannabis consumers and patients.\n \n \n \n 2. Pressurized Sublingual Sprays:\n \n A metered dose spray that gives users an accurate and repeatable experience. In contrast to commonly available ma...